This report is for educational purposes only, and not to provide investment advice.  Before making any investment decision, you should always do your own research or consult a investment professional. Estimates Estimates Estimates
While I try to be accurate, I assume no responsibility for any figure in this spreadsheet. Q1 2025
See my website on stocks or see my blog at the following sites.  https://spbrunner.com/stocks.html https://spbrunner.blogspot.com/
HLS Therapeutics Inc TSXV HLS OTC HLTRF http://www.hlstherapeutics.com/ Fiscal Yr: Dec-31
Year 31-Dec-13 31-Dec-14 31-Dec-15 31-Dec-16 31-Dec-17 31-Dec-18 31-Dec-19 31-Dec-20 31-Dec-21 31-Dec-22 31-Dec-23 31-Dec-24 31-Dec-25 31-Dec-26 31-Dec-27 31-Dec-28 Value Description #Y Item Total G Currency
Accounting Rules IFRS IFRS IFRS IFRS IFRS IFRS IFRS IFRS IFRS IFRS IFRS IFRS IFRS Accounting Rules
USD - CDN$ 1.0636 1.1601 1.3847 1.3427 1.2545 1.3642 1.2988 1.2732 1.2678 1.3544 1.3226 1.4389 1.3706 1.3809 1.3809 1.3809 24.03% <-Total Growth 10 Currency
Change 6.91% 9.07% 19.36% -3.04% -6.57% -6.57% 8.74% -4.79% -1.97% -0.42% 6.83% -2.35% 8.79% -4.75% 0.75% 0.00% 2.18% <-IRR #YR-> 10 USD - CDN$
5 year Running Average 1.0555 1.0233 1.0460 1.1241 1.1892 1.2411 1.3012 1.3290 1.3067 1.2917 1.3117 1.3034 1.3314 1.3509 1.3735 1.3788 2.07% <-IRR #YR-> 5 USD - CDN$
-1.1601 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 1.4389
-1.2988 0.0000 0.0000 0.0000 0.0000 1.4389
Cost of Sales, Regulatory $8.8 $11.6 $11.4 $13.5 $22.0 $24.3 $28.6 $33.1 $31.4 $27.2 $27.7 <-12 mths 1.88% 207.71% <-Total Growth 9 Cost of Sales, Regulatory US$
Change 30.91% -1.79% 18.67% 63.21% 10.54% 17.45% 15.90% -5.14% -13.43% 1.88% <-12 mths 113.97% 15.90% <-Median-> 9 Change US$
Ratio 0.16 0.15 0.18 0.25 0.39 0.41 0.46 0.52 0.55 0.49 0.50 <-12 mths 1.44% 0.40 <-Median-> 10 Ratio US$
General & Admin $7.0 $8.0 $10.0 $12.8 $13.0 $11.7 $12.0 $8.4 $10.2 $10.6 $10.7 <-12 mths 0.83% 52.54% <-Total Growth 9 General & Admin US$
Change 15.02% 25.29% 27.70% 1.68% -9.99% 2.47% -30.13% 21.51% 4.09% 0.83% <-12 mths -79.73% 4.09% <-Median-> 9 Change US$
Ratio 0.13 0.11 0.16 0.24 0.23 0.20 0.20 0.13 0.18 0.19 0.19 <-12 mths 0.39% 0.19 <-Median-> 10 Ratio US$
Total $15.8 $19.6 $21.4 $26.3 $35.0 $36.0 $40.6 $41.5 $41.6 $37.8 $38.4 <-12 mths 1.58% 139.34% <-Total Growth 9 Total US$
Change 23.91% 9.29% 22.90% 33.23% 2.91% 12.58% 2.27% 0.25% -9.13% 1.58% <-12 mths 117.32% 9.29% <-Median-> 9 Change US$
Ratio 0.29 0.26 0.35 0.49 0.62 0.60 0.66 0.66 0.73 0.68 0.69 <-12 mths 1.14% 0.61 <-Median-> 10 Ratio US$
$55.741 <-12 mths 0.43%
Revenue US$* $19.956 $54.031 $75.082 $61.415 $54.160 $56.109 $60.009 $61.467 $63.074 $56.619 $55.500 $58.00 $64.31 $77.20 178.11% <-Total Growth 10 Revenue US$
Increase 170.75% 38.96% -18.20% -11.81% 3.60% 6.95% 2.43% 2.61% -10.23% -1.98% 4.50% 10.88% 20.04% 10.77% <-IRR #YR-> 10 Revenue 178.11% US$
5 year Running Average $52.929 $60.159 $61.355 $58.632 $58.964 $59.456 $59.334 $58.932 $59.501 $62.326 -0.22% <-IRR #YR-> 5 Revenue -1.09% US$
Revenue per Share $0.86 $2.14 $2.97 $2.25 $1.74 $1.76 $1.85 $1.90 $1.97 $1.78 $1.77 $1.85 $2.06 $2.47 -0.28% <-IRR #YR-> 5 5 yr Running Average #DIV/0! US$
Increase 38.96% -24.25% -22.50% 1.11% 4.88% 2.73% 3.82% -9.71% -0.35% 4.50% 10.88% 20.04% -0.28% <-IRR #YR-> 5 5 yr Running Average -1.37% US$
5 year Running Average $1.99 $2.17 $2.12 $1.90 $1.85 $1.85 $1.86 $1.86 $1.89 $1.99 7.55% <-IRR #YR-> 10 Revenue per Share 107.01% US$
P/S (Price/Sales) Med 10.66 4.12 2.97 4.12 8.79 8.29 7.41 4.80 2.60 1.75 1.87 1.74 0.00 0.00 0.13% <-IRR #YR-> 5 Revenue per Share 0.65% US$
P/S (Price/Sales) Close 9.66 3.57 2.57 5.17 10.88 7.85 6.24 3.82 1.62 1.51 1.93 1.76 1.59 1.32 -1.18% <-IRR #YR-> 6 5 yr Running Average #DIV/0! US$
*Revenue in M US $  P/S Med 10 yr  4.12 5 yr  2.60 -57.36% Diff M/C -3.11% <-IRR #YR-> 5 5 yr Running Average -14.62% US$
-$20 $0 $0 $0 $0 $0 $0 $0 $0 $0 $56
-$56 $0 $0 $0 $0 $56
-$60 $0 $0 $0 $0 $59
-$60 $0 $0 $0 $0 $59
-$0.86 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.77
-$1.76 $0.00 $0.00 $0.00 $0.00 $1.77
-$1.99 $0.00 $0.00 $0.00 $0.00 $0.00 $1.86
-$2.17 $0.00 $0.00 $0.00 $0.00 $1.86
$76.973 <-12 mths 1.19%
Revenue CDN $ $27.634 $72.547 $94.190 $83.782 $70.343 $71.438 $76.079 $83.251 $83.422 $81.469 $76.068 $80.09 $88.81 $106.61 175.27% <-Total Growth 10 Revenue CDN$
Increase 29.83% -11.05% -16.04% 1.56% 6.50% 9.43% 0.21% -2.34% -6.63% 5.29% 10.88% 20.04% 10.66% <-IRR #YR-> 10 Revenue 175.27% CDN$
5 year Running Average $69.699 $78.460 $79.167 $76.979 $76.907 $79.132 $80.058 $80.860 $81.971 $86.608 1.26% <-IRR #YR-> 5 Revenue 6.48% CDN$
Revenue per Share $1.19 $2.87 $3.73 $3.07 $2.26 $2.24 $2.34 $2.57 $2.61 $2.56 $2.43 $2.56 $2.84 $3.41 0.40% <-IRR #YR-> 5 5 yr Running Average #DIV/0! CDN$
Increase 29.83% -17.62% -26.22% -0.88% 4.43% 9.75% 1.38% -1.77% -5.08% 5.29% 10.88% 20.04% 0.40% <-IRR #YR-> 5 5 yr Running Average 2.04% CDN$
5 year Running Average $2.62 $2.84 $2.73 $2.50 $2.41 $2.47 $2.50 $2.55 $2.60 $2.76 7.44% <-IRR #YR-> 10 Revenue per Share 104.89% CDN$
P/S (Price/Sales) Med 10.66 4.12 2.97 3.97 8.50 8.25 7.51 4.71 2.65 1.60 1.95 1.79 0.00 0.00 1.62% <-IRR #YR-> 5 Revenue per Share 8.35% CDN$
P/S (Price/Sales) Close 9.66 3.57 2.57 4.77 11.26 8.02 6.40 3.82 1.51 1.53 1.98 1.75 1.58 2.10 -0.77% <-IRR #YR-> 6 5 yr Running Average #DIV/0! CDN$
*Revenue in M CDN $  P/S Med 10 yr  4.04 5 yr  2.65 -56.75% Diff M/C -2.45% <-IRR #YR-> 5 5 yr Running Average -11.67% CDN$
-$28 $0 $0 $0 $0 $0 $0 $0 $0 $0 $76
-$71 $0 $0 $0 $0 $76
-$78 $0 $0 $0 $0 $80
-$78 $0 $0 $0 $0 $80
-$1.19 $0 $0 $0 $0 $0 $0 $0 $0 $0.00 $2.43
-$2.24 $0 $0 $0 $0.00 $2.43
-$2.62 $0.00 $0.00 $0.00 $0.00 $0.00 $2.50
-$2.84 $0.00 $0.00 $0.00 $0.00 $2.50
-$0.36 <-12 mths 7.69%
EPS Basic US$ -$0.92 -$0.60 -$0.24 -$0.92 -$0.67 -$0.48 -$0.41 -$0.73 -$0.85 -$0.62 -$0.39 57.61% <-Total Growth 10 EPS Basic
EPS Diluted* US$ -$0.92 -$0.60 -$0.24 -$0.92 -$0.67 -$0.48 -$0.41 -$0.73 -$0.85 -$0.62 -$0.39 -$0.20 -$0.03 $0.07 57.61% <-Total Growth 10 EPS Diluted US$
Increase 34.78% 60.00% -283.33% 27.17% 28.36% 14.58% -78.05% -16.44% 27.06% 37.10% 48.72% 85.00% 333.33% 0 10 10 Years of Data, EPS P or N
Earnings Yield -7.9% -3.1% -7.9% -3.5% -3.5% -3.6% -10.1% -26.6% -23.0% -11.4% -6.1% -0.9% 2.1% -8.22% <-IRR #YR-> 10 Earnings per Share 35.00% US$
5 year Running Average -$0.67 -$0.58 -$0.54 -$0.64 -$0.63 -$0.62 -$0.60 -$0.56 -$0.42 -$0.23 3.50% <-IRR #YR-> 5 Earnings per Share 18.75% US$
10 year Running Average -$0.64 -$0.59 -$0.55 -$0.53 -$0.43 -1.82% <-IRR #YR-> 6 5 yr Running Average #DIV/0! US$
* Diluted ESP per share US$ E/P 10 Yrs -7.89% 5Yrs -11.37% 0.61% <-IRR #YR-> 5 5 yr Running Average -3.09% US$
$0.92 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$0.39
$0.48 $0.00 $0.00 $0.00 $0.00 -$0.39
$0.67 $0.00 $0.00 $0.00 $0.00 $0.00 -$0.60
$0.58 $0.00 $0.00 $0.00 $0.00 -$0.60
-$0.49 <-12 mths -7.69%
EPS Basic CDN$ -$1.27 -$0.81 -$0.30 -$1.26 -$0.87 -$0.61 -$0.52 -$0.99 -$1.12 -$0.89 -$0.53 58.04% <-Total Growth 10 EPS Basic CDN$
EPS Diluted   -$1.27 -$0.81 -$0.30 -$1.26 -$0.87 -$0.61 -$0.52 -$0.99 -$1.12 -$0.89 -$0.53 -$0.28 -$0.04 $0.10 58.04% <-Total Growth 10 EPS Diluted CDN$
Increase 36.76% 62.63% -316.85% 30.67% 29.77% 14.95% -90.21% -13.70% 20.64% 40.08% 48.33% 85.00% 333.33% 0 10 10 Years of Data, EPS P or N
Earnings Yield -7.9% -3.1% -8.6% -3.4% -3.4% -3.5% -10.1% -28.5% -22.7% -11.1% -6.2% -0.9% 1.4% -8.32% <-IRR #YR-> 10 Earnings per Share -2.83% CDN$
5 year Running Average -$0.90 -$0.77 -$0.71 -$0.85 -$0.82 -$0.83 -$0.81 -$0.76 -$0.57 -$0.33 -2.64% <-IRR #YR-> 5 Earnings per Share 12.53% CDN$
10 year Running Average -$0.86 -$0.79 -$0.74 -$0.71 -$0.58 -1.72% <-IRR #YR-> 6 5 yr Running Average #DIV/0! CDN$
* Diluted ESP per share  E/P 10 Yrs -8.22% 5Yrs -11.09% 1.10% <-IRR #YR-> 5 5 yr Running Average -5.63% CDN$
$1.27 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$0.53
$0.61 $0.00 $0.00 $0.00 $0.00 -$0.53
$0.90 $0.00 $0.00 $0.00 $0.00 $0.00 -$0.81
$0.77 $0.00 $0.00 $0.00 $0.00 -$0.81
Dividends* US$ $0.00 Estimates Dividend*
Increase #DIV/0! Estimates Increase
Payout Ratio EPS 0.00% Estimates Payout Ratio EPS
Real Dividend is  $0.04
Special Dividend US$ $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 0.00% <-Median-> 8 Special Dividends  US$
Dividends* US$ $0.04 $0.15 $0.16 $0.16 $0.15 $0.08 $0.00 $0.00 $0.00 $0.00 $0.00 -100.00% <-Total Growth 7 Dividends US$
Increase 320.14% 2.01% 0.43% -6.39% -48.80% -100.00% #DIV/0! #DIV/0! #DIV/0! #DIV/0! 3 3 7 Years of data, Count P, N US$
Average Increases 5 Year Running 64.4% 64.5% 63.2% 53.5% -30.6% #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! <-Median-> 5 Average Incr 5 Year Running US$
Dividends 5 Yr Running $0.12 $0.13 $0.16 $0.14 $0.11 $0.08 $0.04 $0.02 $0.00 -39.70% <-Total Growth 5 Dividends 5 Yr Running US$
Yield H/L Price 0.40% 1.01% 1.07% 1.15% 1.62% 1.47% 0.00% 0.00% 0.00% 1.04% <-Median-> 8 Yield H/L Price US$
Yield on High  Price 0.30% 0.77% 0.82% 0.93% 1.23% 0.99% 0.00% 0.00% 0.00% 0.80% <-Median-> 8 Yield on High  Price US$
Yield on Low Price 0.58% 1.43% 1.55% 1.52% 2.37% 2.91% 0.00% 0.00% 0.00% 1.47% <-Median-> 8 Yield on Low Price US$
Yield on Close Price 0.32% 0.81% 1.14% 1.37% 2.04% 2.37% 0.00% 0.00% 0.00% 0.00% 0.00% 0.97% <-Median-> 8 Yield on Close Price US$
Payout Ratio EPS 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% <-Median-> 8 DPR EPS US$
DPR EPS 5 Yr Running 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% <-Median-> 0 DPR EPS 5 Yr Running US$
Payout Ratio CFPS 3.05% 18.11% 53.50% 31.16% 28.20% 15.31% 0.00% 0.00% 0.00% #VALUE! #DIV/0! 16.71% <-Median-> 8 DPR CF US$
DPR CF 5 Yr Running 13.54% 16.10% 24.20% 25.95% 26.01% 16.40% 9.10% #VALUE! #DIV/0! 20.30% <-Median-> 6 DPR CF 5 Yr Running US$
Payout Ratio CFPS WC 3.81% 19.24% 29.39% 27.31% 31.04% 18.26% 0.00% 0.00% 0.00% #VALUE! #DIV/0! 18.75% <-Median-> 8 DPR CF WC US$
DPR CF WC 5 Yr Running 13.54% 14.75% 24.36% 24.70% 23.29% 17.02% 10.35% #VALUE! #DIV/0! 20.15% <-Median-> 2 DPR CF WC 5 Yr Running US$
Mediuan 5 Yrs 10 Yr Med 10 Yr Cl 1.04% 0.97% 5 Yr Med 5 Yr Cl 1.11% 1.20% 5 Yr Med Payout 0.00% 24.64% 23.28% #NUM! <-IRR #YR-> 5 Dividends -100.00% US$
* Dividends per share US$, paid in CDN$ 10 Yr Med and Cur. -100.00% -100.00% 5 Yr Med and Cur. 26.74% 17.77% Last Div Inc ---> $0.05 5.0% 0.0% #NUM! <-IRR #YR-> 7 Dividends #DIV/0! US$
$0.00 -$0.16 $0.00 $0.00 $0.00 $0.00 $0.00
-$0.15 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Historical Dividends Historical High Div FALSE Low Div 0.21% Ave Div 0.21% Med Div 1.04% Close Div 0.97% Historical Dividends US$
High/Ave/Median Values Curr diff Exp. #DIV/0! Exp -100.00% Exp. -100.00% Exp. -100.00% Exp. -100.00% High/Ave/Median  US$
Future Dividend Yield Div Yd #NUM! earning in 5 Years at IRR of #NUM! Div Inc. #NUM! Future Dividend Yield US$
Future Dividend Yield Div Yd #NUM! earning in 10 Years at IRR of #NUM! Div Inc. #NUM! Future Dividend Yield US$
Future Dividend Yield Div Yd #NUM! earning in 15 Years at IRR of #NUM! Div Inc. #NUM! Future Dividend Yield US$
Future Dividend Paid Div Paid #NUM! earning in 5 Years at IRR of #NUM! Div Inc. #NUM! Future Dividend Paid
Future Dividend Paid Div Paid #NUM! earning in 10 Years at IRR of #NUM! Div Inc. #NUM! Future Dividend Paid
Future Dividend Paid Div Paid #NUM! earning in 15 Years at IRR of #NUM! Div Inc. #NUM! Future Dividend Paid
Dividend Covering Cost Total Div #NUM! over 5 Years at IRR of #NUM! Div Cov. #NUM! Dividend Covering Cost
Dividend Covering Cost Total Div #NUM! over 10 Years at IRR of #NUM! Div Cov. #NUM! Dividend Covering Cost
Dividend Covering Cost Total Div #NUM! over 15 Years at IRR of #NUM! Div Cov. #NUM! Dividend Covering Cost
Dividends CDN$ $0.00 Estimates Dividend*
Increase #DIV/0! Estimates Increase
Payout Ratio EPS 0.00% Estimates Payout Ratio EPS
Real Dividend is  $0.05
Special Dividends CDN$, Paid in CDN$ $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 0.00% <-Median-> 8 Special Dividends CDN$ CDN$
Dividends per Share $0.05 $0.20 $0.20 $0.20 $0.20 $0.10 $0.00 $0.00 $0.00 $0.00 $0.00 -100.00% <-Total Growth 7 Dividends CDN$
Increase 300.00% 0.00% 0.00% 0.00% -50.00% -100.00% #DIV/0! #DIV/0! #DIV/0! #DIV/0! 1 2 7 Years of data, Count P, N CDN$
Average Increases 5 Year Running 0.0% 60.0% 60.0% 60.0% 60.0% 50.0% -30.0% #DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! <-Median-> 7 Average Incr 5 Year Running CDN$
Dividends 5 Yr Running $0.15 $0.16 $0.17 $0.18 $0.14 $0.10 $0.06 $0.02 $0.00 -38.46% <-Total Growth 5 Dividends 5 Yr Running CDN$
Yield H/L Price 0.41% 1.04% 1.08% 1.14% 1.65% 1.45% 0.00% 0.00% 0.00% 1.06% <-Median-> 8 Yield H/L Price CDN$
Yield on High  Price 0.31% 0.78% 0.85% 0.94% 1.26% 0.97% 0.00% 0.00% 0.00% 0.82% <-Median-> 8 Yield on High  Price CDN$
Yield on Low Price 0.62% 1.54% 1.48% 1.44% 2.38% 2.87% 0.00% 0.00% 0.00% 1.46% <-Median-> 8 Yield on Low Price CDN$
Yield on Close Price 0.34% 0.78% 1.11% 1.33% 2.03% 2.53% 0.00% 0.00% 0.00% 0.00% 0.00% 0.95% <-Median-> 8 Yield on Close Price CDN$
Payout Ratio EPS 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% <-Median-> 8 DPR EPS CDN$
DPR EPS 5 Yr Running 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% <-Median-> 0 DPR EPS 5 Yr Running CDN$
Payout Ratio CFPS 3.05% 18.11% 53.50% 31.16% 28.20% 15.31% 0.00% 0.00% 0.00% #VALUE! #DIV/0! 16.71% <-Median-> 8 DPR CF CDN$
DPR CF 5 Yr Running 19.03% 25.85% 25.55% 16.04% 8.94% #VALUE! #DIV/0! 22.29% <-Median-> 4 DPR CF 5 Yr Running CDN$
Payout Ratio CFPS WC 3.81% 19.24% 29.39% 27.31% 31.04% 18.26% 0.00% 0.00% 0.00% #VALUE! #DIV/0! 18.75% <-Median-> 8 DPR CF WC CDN$
DPR CF WC 5 Yr Running 19.27% 24.70% 22.96% 16.65% 10.15% #VALUE! #DIV/0! 21.12% <-Median-> 0 DPR CF WC 5 Yr Running CDN$
Mediuan 5 Yrs 10 Yr Med 10 Yr Cl 1.06% 0.95% 5 Yr Med 5 Yr Cl 1.14% 1.33% 5 Yr Med Payout 0.00% 15.31% 18.26% #NUM! <-IRR #YR-> 5 Dividends -100.00% CDN$
 Div per share (Dividends paid in CDN$.) 10 Yr Med and Cur. -100.00% -100.00% 5 Yr Med and Cur. -100.00% -100.00% Last Div Inc ---> $0.05 $0.05 0.0% #NUM! <-IRR #YR-> 7 Dividends #DIV/0! CDN$
-$0.20 $0.00 $0.00 $0.00 $0.00 $0.00
-$0.20 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Historical Dividends Historical High Div 2.48% Low Div 0.00% 10 Yr High 2.48% 10 Yr Low 0.00% Med Div 1.06% Close Div 0.95% Historical Dividends CDN$
High/Ave/Median Values Curr diff Exp. -100.00% #DIV/0! #DIV/0! Exp. -100.00% #DIV/0! Exp. -100.00% Exp. -100.00% High/Ave/Median  CDN$
Future Dividend Yield Div Yd #NUM! earning in 5.00 Years at IRR of #NUM! Div Inc. #NUM! Future Dividend Yield CDN$
Future Dividend Yield Div Yd #NUM! earning in 10.00 Years at IRR of #NUM! Div Inc. #NUM! Future Dividend Yield CDN$
Future Dividend Yield Div Yd #NUM! earning in 15.00 Years at IRR of #NUM! Div Inc. #NUM! Future Dividend Yield
Future Dividend Paid Div Paid #NUM! earning in 5 Years at IRR of #NUM! Div Inc. #NUM! Future Dividend Paid
Future Dividend Paid Div Paid #NUM! earning in 10 Years at IRR of #NUM! Div Inc. #NUM! Future Dividend Paid
Future Dividend Paid Div Paid #NUM! earning in 15 Years at IRR of #NUM! Div Inc. #NUM! Future Dividend Paid
Dividend Covering Cost Total Div #NUM! over 5 Years at IRR of #NUM! Div Cov. #NUM! Dividend Covering Cost
Dividend Covering Cost Total Div #NUM! over 10 Years at IRR of #NUM! Div Cov. #NUM! Dividend Covering Cost
Dividend Covering Cost Total Div #NUM! over 15 Years at IRR of #NUM! Div Cov. #NUM! Dividend Covering Cost
Yield if held 5 years 1.58% 1.69% 1.81% 0.82% 0.00% 0.00% 0.00% 0.00% 0.00% 1.20% <-Median-> 6 Paid Median Price CDN$
Yield if held 10 years 0.00% 0.00% 0.00% 0.00% 0.00% <-Median-> 1 Paid Median Price CDN$
Cost covered if held 5 years 3.56% 5.49% 7.69% 7.39% 3.64% 2.70% 1.70% 0.82% 0.00% 4.56% <-Median-> 6 Paid Median Price CDN$
Cost covered if held 10 years 7.51% 8.03% 8.59% 7.39% 7.51% <-Median-> 1 Paid Median Price CDN$
Yr  Item Tot. Growth Per Year
Revenue Growth US$ $56.1 $60.0 $61.5 $63.1 $56.6 $55.5 $56 <-12 mths 0.43% -1.09% <-Total Growth 5 Revenue Growth US$ -1.09% -0.22%
EPS Growth -$0.48 -$0.41 -$0.73 -$0.85 -$0.62 -$0.39 -$0.20 <-12 mths 48.72% 18.75% <-Total Growth 5 EPS Growth 18.75% 3.50%
Net Income Growth -$15.3 -$13.1 -$23.6 -$27.5 -$19.7 -$12.4 -$14 <-12 mths -13.47% 18.92% <-Total Growth 5 Net Income Growth 18.92% 3.53%
Cash Flow Growth $9.3 $16.4 $16.9 $15.8 $8.0 $17.1 $20 <-12 mths 16.49% 83.33% <-Total Growth 5 Cash Flow Growth 83.33% 12.89%
Dividend Growth $0.20 $0.20 $0.20 $0.10 $0.00 $0.00 $0.00 <-12 mths #DIV/0! 0.00% <-Total Growth 5 Dividend Growth 0.00% 0.00%
Stock Price Growth $13.84 $11.54 $7.25 $3.19 $2.69 $3.43 $3.26 <-12 mths -4.96% -75.22% <-Total Growth 5 Stock Price Growth -75.22% -24.35%
Revenue Growth US$ $20.0 $54.0 $75.1 $61.4 $54.2 $56.1 $60.0 $61.5 $63.1 $56.6 $55.5 $58 <-this year 4.50% 178.11% <-Total Growth 10 Revenue Growth US$ 178.11% 10.77%
EPS Growth -$0.92 -$0.60 -$0.24 -$0.92 -$0.67 -$0.48 -$0.41 -$0.73 -$0.85 -$0.62 -$0.39 -$0.20 <-this year 48.72% 57.61% <-Total Growth 10 EPS Growth 57.61% 4.65%
Net Income Growth -$9.6 -$14.9 -$6.1 -$24.8 -$19.6 -$15.3 -$13.1 -$23.6 -$27.5 -$19.7 -$12.4 -$6 <-this year 49.61% -28.97% <-Total Growth 10 Net Income Growth -28.97% -3.36%
Cash Flow Growth $21.8 $27.2 $32.7 $26.4 $9.3 $16.4 $16.9 $15.8 $8.0 $17.1 $20 <-this year 16.49% -21.27% <-Total Growth 9 Cash Flow Growth -21.27% -2.62%
Dividend Growth $0.20 $0.20 $0.20 $0.20 $0.10 $0.00 $0.00 $0.00 <-this year #DIV/0! -100.00% <-Total Growth 6 Dividend Growth -100.00% #NUM!
Stock Price Growth $8.28 $7.62 $7.62 $11.63 $18.98 $13.84 $11.54 $7.25 $3.19 $2.69 $3.43 $3.26 <-this year -4.96% -58.58% <-Total Growth 10 Stock Price Growth -58.58% -8.44%
Dividends on Shares $0.00 $4.90 $19.60 $19.60 $19.60 $19.60 $9.80 $0.00 $0.00 $0.00 $0.00 $0.00 $93.10 No of Years 9 Total Divs 12/31/16
Paid  $1,003.32 $937.42 $1,435.70 $2,499.00 $1,764.00 $1,470.00 $963.34 $387.10 $385.14 $472.36 $439.04 $439.04 $701.00 $472.36 No of Years 9 Worth $10.24 97.68
Total $565.46
Assumed EPS $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01
Graham No. $1.61 $1.45 $1.42 $1.34 $1.29 $1.23 $1.19 $1.09 $0.93 $0.85 $0.78 $0.76 -51.70% <-Total Growth 10 Graham Price CDN$
Price/GP Ratio Med 7.84 8.17 7.79 9.12 14.87 15.01 14.82 11.16 7.43 4.80 6.08 6.02 8.64 <-Median-> 10 Price/GP Ratio CDN$
Price/GP Ratio Hi 8.58 9.27 8.84 12.17 19.69 19.07 17.98 14.59 11.10 6.07 7.34 6.41 11.64 <-Median-> 10 Price/GP Ratio CDN$
Price/GP Ratio Low 7.10 7.07 6.74 6.07 10.05 10.95 11.66 7.73 3.76 3.53 4.83 5.62 6.90 <-Median-> 10 Price/GP Ratio CDN$
Price/GP Ratio Cl 7.10 7.07 6.74 10.97 19.69 14.58 12.62 9.05 4.25 4.61 6.18 5.87 8.06 <-Median-> 10 Price/GP Ratio CDN$
Prem /Disc. Close 610.12% 606.79% 573.99% 997.37% 1869.34% 1358.26% 1161.92% 804.81% 325.24% 361.09% 518.09% 487.30% 705.80% <-Median-> 10 Graham Price CDN$
Close CDN$ re Exchange Rate $11.47 $10.24 $9.57 $15.87 $24.65 $17.62 $14.63 $9.82 $4.22 $3.87 $4.70 $4.50 -59.00% <-Total Growth 10 Close CDN$ re Exchange Rate CDN$
Difference - amount $0.00 $0.00 $0.00 $1.22 -$0.85 -$0.38 -$0.37 -$0.01 $0.27 -$0.06 -$0.12 $0.02 Differnce
Difference - percentage 0.00% 0.00% 0.00% -7.66% 3.44% 2.15% 2.53% 0.11% -6.38% 1.53% 2.53% -0.48%
Price Close CDN$ $11.47 $10.24 $9.57 $14.65 $25.50 $18.00 $15.00 $9.83 $3.95 $3.93 $4.82 $4.48 $4.48 $7.15 -57.96% <-Total Growth 10 Stock Price CDN$
Increase -10.71% -6.57% 53.15% 74.06% -29.41% -16.67% -34.47% -59.82% -0.51% 22.65% -7.05% 0.00% 59.67% -14.37 <-Median-> 10 CAPE (10 Yr P/E) CDN$
P/E -9.00 -12.71 -31.77 -11.67 -29.30 -29.45 -28.86 -9.94 -3.51 -4.41 -9.02 -16.22 -108.14 74.00 -23.17% <-IRR #YR-> 5 Stock Price -73.22% CDN$
Trailing P/E -8.04 -11.87 -48.66 -20.32 -20.68 -24.54 -18.91 -4.00 -3.50 -5.40 -8.38 -16.22 -172.67 -8.30% <-IRR #YR-> 10 Stock Price -57.96% CDN$
CAPE (10 Yr P/E) -14.13 -14.61 -14.88 -14.71 -16.86 -22.46% <-IRR #YR-> 5 Price & Dividend #DIV/0!
Median 5 yrs D.  per yr 1.24% 0.71% % Tot Ret 0.00% 0.00% T P/E -15.39 -5.40 P/E:  -12.19 -9.02 -7.06% <-IRR #YR-> 10 Price & Dividend #DIV/0! CDN$
CAPE Diff 12.86%
-$18.00 $0.00 $0.00 $0.00 $0.00 $4.82
-$11.47 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $4.82
-$18.00 $0.20 $0.20 $0.10 $0.00 $4.82
-$11.47 $0.00 $0.00 $0.05 $0.20 $0.20 $0.20 $0.20 $0.10 $0.00 $4.82
Price H/L Med. CDN$ $12.66 $11.83 $11.06 $12.18 $19.26 $18.53 $17.62 $12.13 $6.90 $4.09 $4.75 $4.59 -62.51% <-Total Growth 10 Stock Price CDN$
Increase -6.51% -6.57% 10.13% 58.15% -3.77% -4.94% -31.17% -43.09% -40.72% 16.01% -3.27% -9.34% <-IRR #YR-> 10 Stock Price -62.51% CDN$
P/E -9.93 -14.69 -36.72 -9.70 -22.13 -30.32 -33.89 -12.26 -6.14 -4.58 -8.88 -16.62 -23.85% <-IRR #YR-> 5 Stock Price -74.39% CDN$
Trailing P/E -9.29 -13.72 -40.44 -15.34 -21.29 -28.82 -23.33 -6.98 -3.64 -5.32 -8.59 -9.34% <-IRR #YR-> 10 Price & Dividend CDN$
P/E on Running 5 yr Average -24.11 -24.76 -14.28 -8.39 -4.94 -5.84 -6.01 -23.63% <-IRR #YR-> 5 Price & Dividend CDN$
P/E on Running 10 yr Average -6.23 -12.26 P/E Ratio Historical Median CDN$
Median 10, 5 Yrs D.  per yr 0.00% 0.22% % Tot Ret 0.00% -0.92% T P/E -14.53 -6.98 P/E:  -13.48 -8.88 Count 11 Years of data
-$12.66 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $4.75
-$18.53 $0.00 $0.00 $0.00 $0.00 $4.75
-$12.66 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $4.75
-$18.53 $0.20 $0.00 $0.00 $0.00 $4.75
High Month Aug Nov Dec Jan Mar Mar Jan Apr Sep Jan
Price High CDN$ $13.85 $13.43 $12.55 $16.25 $25.50 $23.54 $21.37 $15.85 $10.31 $5.17 $5.72 $4.89 -58.69% <-Total Growth 10 Stock Price CDN$
Increase -3.04% -6.57% 29.53% 56.92% -7.69% -9.22% -25.83% -34.95% -49.85% 10.64% -14.51% -8.46% <-IRR #YR-> 10 Stock Price -58.69% CDN$
P/E -10.87 -16.67 -41.67 -12.95 -29.30 -38.52 -41.11 -16.03 -9.17 -5.80 -10.70 -17.71 -24.64% <-IRR #YR-> 5 Stock Price -75.70% CDN$
Trailing P/E -10.54 -15.57 -53.97 -20.32 -27.05 -34.97 -30.49 -10.43 -4.60 -6.41 -9.15 -16.03 P/E Ratio Historical Median CDN$
Median 10, 5 Yrs T P/E -17.94 -10.43 P/E:  -16.35 -10.70 -10.80 P/E Ratio Historical High CDN$
-$13.85 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $5.72
-$23.54 $0.00 $0.00 $0.00 $0.00 $5.72
Low Month Jan Oct Sep Sep Jan Sep Dec Dec Dec Aug Jan Mar
Price Low CDN$ $11.47 $10.24 $9.57 $8.10 $13.01 $13.52 $13.86 $8.40 $3.49 $3.01 $3.77 $4.29 -67.12% <-Total Growth 10 Stock Price CDN$
Increase -10.71% -6.57% -15.32% 60.62% 3.92% 2.51% -39.39% -58.45% -13.75% 25.25% 13.79% -10.53% <-IRR #YR-> 10 Stock Price -67.12% CDN$
P/E -9.00 -12.71 -31.77 -6.45 -14.95 -22.12 -26.66 -8.50 -3.10 -3.37 -7.05 -15.53 -22.54% <-IRR #YR-> 5 Stock Price -72.12% CDN$
Trailing P/E -8.04 -11.87 -26.90 -10.37 -15.54 -22.68 -16.16 -3.53 -2.68 -4.23 -8.03 -9.00 P/E Ratio Historical Median CDN$
Median 10, 5 Yrs T P/E -11.12 -4.23 P/E:  -10.60 -7.05 -17.82 P/E Ratio Historical Low CDN$
-$11.47 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $3.77
-$13.52 $0.00 $0.00 $0.00 $0.00 $3.77
Price Close CDN$ - US$ $8.28 $7.62 $7.62 $10.74 $19.63 $14.14 $11.83 $7.26 $2.99 $2.73 $3.52 $3.24 $3.24 $5.18 -57.53% <-Total Growth 10
Difference 0.00% 0.00% -7.66% 3.44% 2.15% 2.53% 0.11% -6.38% 1.53% 2.53% -0.48% -0.48% 58.90%
Price Close US$ $8.28 $7.62 $7.62 $11.63 $18.98 $13.84 $11.54 $7.25 $3.19 $2.69 $3.43 $3.26 $3.26 $3.26 -58.58% <-Total Growth 10 Stock Price US$
Increase -7.91% 0.00% 52.53% 63.20% -27.08% -16.62% -37.18% -56.00% -15.67% 27.51% -4.96% 0.00% 0.00% -14.62 <-Median-> 10 CAPE (10 Yr P/E)
P/E -9.00 -12.71 -31.77 -12.64 -28.33 -28.83 -28.15 -9.93 -3.75 -4.34 -8.79 -16.30 -108.67 46.57 -24.35% <-IRR #YR-> 5 Stock Price -75.22% US$
Trailing P/E -8.29 -12.71 -48.46 -20.63 -20.66 -24.04 -17.68 -4.37 -3.16 -5.53 -8.36 -16.30 -108.67 -8.49% <-IRR #YR-> 9 Stock Price -58.58% US$
CAPE (10 Yr P/E) -14.39 -14.86 -15.14 -14.92 -16.40 -23.64% <-IRR #YR-> 5 Price & Dividend -75.07% US$
Median 10, 5 Yrs D.  per yr 1.48% 0.71% % Tot Ret 0.00% 0.00% T P/E -15.20 -5.53 P/E:  -12.67 -8.79 -7.01% <-IRR #YR-> 9 Price & Dividend -57.73% US$
-$13.84 $0.00 $0.00 $0.00 $0.00 $3.43
-$7.62 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $3.43
-$13.84 $0.16 $0.15 $0.08 $0.00 $3.43
-$7.62 $0.00 $0.04 $0.15 $0.16 $0.16 $0.15 $0.08 $0.00 $3.43
Price H/L Med. US$ $9.14 $8.81 $8.81 $9.28 $15.32 $14.63 $13.70 $9.12 $5.14 $3.11 $3.31 $3.22 -63.79% <-Total Growth 10 Stock Price US$
Increase -3.58% 0.00% 5.25% 65.18% -4.54% -6.36% -33.42% -43.68% -39.44% 6.43% -2.72% -9.66% <-IRR #YR-> 10 Stock Price -63.79% US$
P/E -9.93 -14.69 -36.72 -10.08 -22.87 -30.47 -33.40 -12.49 -6.04 -5.02 -8.49 -16.10 -25.71% <-IRR #YR-> 5 Stock Price -77.37% US$
Trailing P/E -9.58 -14.69 -38.65 -16.65 -21.83 -28.53 -22.24 -7.03 -3.66 -5.34 -8.26 -8.38% <-IRR #YR-> 10 Price & Dividend US$
P/E on Running 5 yr Average -25.13 -25.17 -14.20 -8.18 -5.03 -5.52 -5.77 -25.03% <-IRR #YR-> 5 Price & Dividend US$
P/E on Running 10 yr Average -4.83 -5.60 -5.84 -12.49 P/E Ratio Historical Median
Median 10, 5 Yrs D.  per yr 1.28% 0.68% % Tot Ret -15.30% -2.72% T P/E -15.67 -7.03 P/E:  -13.59 -8.49
-$9.14 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $3.31
-$14.63 $0.00 $0.00 $0.00 $0.00 $3.31
-$9.14 $0.00 $0.00 $0.04 $0.15 $0.16 $0.16 $0.15 $0.08 $0.00 $3.31
-$14.63 $0.16 $0.15 $0.08 $0.00 $3.31
High Month Nov Dec Jan Apr Feb Jan Apr Oct Apr
Price High US$ $10.00 $10.00 $10.00 $12.21 $19.89 $19.10 $16.99 $12.00 $7.67 $4.00 $4.02 $3.44 -59.80% <-Total Growth 10 Stock Price US$
Increase 0.00% 0.00% 22.10% 62.90% -3.97% -11.05% -29.37% -36.08% -47.85% 0.50% -14.43% -8.71% <-IRR #YR-> 10 Stock Price -59.80% US$
P/E -10.87 -16.67 -41.67 -13.27 -29.69 -39.79 -41.44 -16.44 -9.02 -6.45 -10.31 -17.20 -26.78% <-IRR #YR-> 5 Stock Price -78.95% US$
Trailing P/E -10.87 -16.67 -50.88 -21.62 -28.51 -35.40 -29.27 -10.51 -4.71 -6.48 -8.82 -16.44 P/E Ratio Historical Median US$
Median 10, 5 Yrs T P/E -19.14 -10.51 P/E:  -16.55 -10.31 -10.64 P/E Ratio Historical High US$
-$10.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $4.02
-$19.10 $0.00 $0.00 $0.00 $0.00 $4.02
Low Month Feb Sep Dec Nov Nov Aug Jan Mar
Price Low US$ $8.28 $7.62 $7.62 $6.34 $10.75 $10.15 $10.40 $6.24 $2.60 $2.22 $2.60 $3.00 -68.60% <-Total Growth 10 Stock Price US$
Increase -7.91% 0.00% -16.85% 69.56% -5.58% 2.46% -40.05% -58.30% -14.62% 17.12% 15.38% -10.94% <-IRR #YR-> 10 Stock Price -68.60% US$
P/E -9.00 -12.71 -31.77 -6.89 -16.04 -21.15 -25.37 -8.54 -3.06 -3.58 -6.67 -15.00 -23.84% <-IRR #YR-> 5 Stock Price -74.38% US$
Trailing P/E -8.29 -12.71 -26.42 -11.68 -15.15 -21.67 -15.21 -3.56 -2.61 -4.19 -7.69 -9.00 P/E Ratio Historical Median US$
Median 10, 5 Yrs T P/E -12.20 -4.19 P/E:  -10.62 -6.67 -18.09 P/E Ratio Historical Low US$
-$8.28 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.60
-$10.15 $0.00 $0.00 $0.00 $0.00 $2.60
Free Cash Flow  Mk Sc US$ $9.31 $12.56 $16.90 $15.75 $7.99 $16.92 $10.50 Free Cash Flow  Mk Sc US$ US$
Change 34.94% 34.55% -6.80% -49.28% 111.82% -37.94%
Free Cash Flow WSJ CDN$ $28.41 $35.03 $27.47 $33.45 $12.48 $20.54 $22.00 $19.42 $9.31 $22.0 -22.57% <-Total Growth 9 Free Cash Flow WSJ CDN$ CDN$
Change 23.32% -21.57% 21.76% -62.68% 64.51% 7.10% -11.72% -52.05% 136.22% 7.10% <-Median-> 9 Change CDN$
Free Cash Flow WSJ US$ Calc $21.16 $27.92 $20.14 $25.75 $9.81 $16.20 $16.24 $14.68 $6.47 $16.05 -24.14% <-Total Growth 9 Free Cash Flow WSJ US$ Calc US$
Change 31.99% -27.88% 27.89% -61.93% 65.21% 0.25% -9.60% -55.93% 147.99% 0.25% <-Median-> 9 Change US$
Free Cash Flow MS Old -$2.94 $21.48 $26.43 $31.97 $23.85 -$35.33 $11.92 $6.79 $15.60
Change
Free Cash Flow MS -$9.30 $0.06 $35.43 $25.51 $22.30 -$27.67 $14.94 $5.25 $10.56 $6.85 $10.69 $10.5 214.95% <-Total Growth 10 Free Cash Flow US$
Change 100.65% 58950.00% -28.00% -12.58% -224.08% 153.99% -64.86% 101.14% -35.13% 56.06% -1.78% #NUM! <-IRR #YR-> 5 Free Cash Flow MS 138.63% US$
FCF/CF from Op Ratio 0.00 1.30 0.78 0.84 -2.96 0.91 0.31 0.67 0.86 0.62 0.53 #NUM! <-IRR #YR-> 10 Free Cash Flow MS 214.95% US$
Dividends paid $1.05 $4.33 $4.75 $5.12 $4.96 $2.40 $0.00 $0.00 $0.00 -100.00% <-Total Growth 7 Dividends paid US$
Percentage paid 0.00% 0.00% 0.00% 4.10% 19.43% -17.16% 34.28% 94.51% 22.71% 0.00% 0.00% 0.00% $0.02 <-Median-> 10 Percentage paid US$
5 Year Coverage 7.27% 18.21% 21.63% 50.12% 84.96% 173.52% 25.85% 16.78% 5 Year Coverage US$
Dividend Coverage Ratio 0.00 0.00 0.00 24.36 5.15 -5.83 2.92 1.06 4.40 0.00 0.00 0.00 0.53 <-Median-> 10 Dividend Coverage Ratio US$
5 Year of Coverage 13.76 5.49 4.62 2.00 1.18 0.58 3.87 5.96 5 Year of Coverage US$
Market Cap US$ $192.743 $192.743 $192.743 $317.444 $589.502 $440.422 $374.487 $234.578 $102.016 $85.523 $107.269 $101.952 $101.952 $101.952 -44.35% <-Total Growth 10 Market Cap  US$
Market Cap CDN$ $266.900 $258.796 $241.796 $399.876 $792.008 $572.803 $486.768 $318.056 $126.321 $124.947 $150.739 $140.106 $140.106 $223.703 -43.52% <-Total Growth 10 Market Cap  CDN$
Diluted # of Shares in Million 23.278 24.775 25.278 26.953 29.308 31.714 32.184 32.433 32.263 31.839 31.839 31.274 36.78% <-Total Growth 10 Diluted
Change 6.43% 2.03% 6.62% 8.74% 8.21% 1.48% 0.77% -0.52% -1.31% 0.00% -1.78% 1.76% <-Median-> 10 Change
Difference Diluted/Basic 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% <-Median-> 10 Difference Diluted/Basic
Basic # of Shares in Millions 23.278 24.775 25.278 26.953 29.308 31.714 32.184 32.433 32.263 31.839 31.839 31.274 36.78% <-Total Growth 10 Basic
Change 6.43% 2.03% 6.62% 8.74% 8.21% 1.48% 0.77% -0.52% -1.31% 0.00% -1.78% 1.76% <-Median-> 10 Change
Difference Basic/Outstanding 0.00% 2.03% 0.00% 1.27% 5.97% 0.34% 0.83% -0.24% -0.88% -0.15% -1.78% 0.00% 0.17% <-Median-> 10 Difference Basic/Outstanding
$19.954 <-12 mths 16.49%
# of Shares in Millions 23.278 25.278 25.278 27.295 31.059 31.822 32.451 32.356 31.980 31.793 31.274 31.274 31.274 31.274 -0.35% <-IRR #YR-> 5 Shares 34.35%
Change 8.59% 0.00% 7.98% 13.79% 2.46% 1.98% -0.29% -1.16% -0.58% -1.63% 0.00% 0.00% 0.00% -0.35% <-IRR #YR-> 5 Shares -1.72%
CF fr Op $M US$ $21.758 $27.166 $32.747 $26.408 $9.344 $16.429 $16.942 $15.789 $8.003 $17.130 $19.954 <-12 mths -21.27% <-Total Growth 9 Cash Flow US$
Increase 24.86% 20.54% -19.36% -64.62% 75.82% 3.12% -6.81% -49.31% 114.04% 16.49% <-12 mths SO Buy Back, DRIP S Iss
5 year Running Average $23 $22 $20 $17 $13 $15 $16 <-12 mths -36.73% <-Total Growth 5 CF 5 Yr Running US$
CFPS US$ $0.86 $1.07 $1.20 $0.85 $0.29 $0.51 $0.52 $0.49 $0.25 $0.55 $0.64 <-12 mths -36.36% <-Total Growth 9 Cash Flow per Share US$
Increase 24.86% 11.64% -29.13% -65.47% 72.42% 3.43% -5.71% -49.01% 117.60% 16.49% <-12 mths -2.62% <-IRR #YR-> 9 Cash Flow #DIV/0! US$
5 year Running Average $0.86 $0.78 $0.67 $0.53 $0.41 $0.46 $0.49 <-12 mths 12.89% <-IRR #YR-> 5 Cash Flow 83.33% US$
P/CF on Med Price 10.24 8.20 7.73 18.02 49.81 27.05 17.41 10.40 12.35 6.04 5.05 <-12 mths -4.90% <-IRR #YR-> 9 Cash Flow per Share #DIV/0! US$
P/CF on Closing Price 8.86 7.10 9.69 22.32 47.13 22.79 13.85 6.46 10.69 6.26 5.11 <-12 mths 13.28% <-IRR #YR-> 5 Cash Flow per Share 86.54% US$
-55.09% Diff M/C -11.50% <-IRR #YR-> 5 CFPS 5 yr Running #DIV/0! US$
$15.52 <-12 mths 7.12%
Excl.Working Capital CF -$7.265 $8.443 -$6.455 -$1.549 $7.665 $2.313 -$1.547 -$2.547 $1.802 -$2.645 $15.516 <-12 mths -11.50% <-IRR #YR-> 5 CFPS 5 yr Running -45.71% US$
CF fr Op $M WC US$ $14.493 $35.609 $26.292 $24.859 $17.009 $18.742 $15.395 $13.242 $9.805 $14.485 $15.516 <-12 mths -0.06% <-Total Growth 9 Cash Flow less WC US$
Increase 145.70% -26.16% -5.45% -31.58% 10.19% -17.86% -13.99% -25.96% 47.73% 7.12% <-12 mths -0.01% <-IRR #YR-> 9 Cash Flow less WC #DIV/0! US$
5 year Running Average $24 $25 $20 $18 $15 $14 $14 <-12 mths -3.16% <-IRR #YR-> 5 Cash Flow less WC -14.84% US$
CFPS Excl. WC US$ $0.57 $1.41 $0.96 $0.80 $0.53 $0.58 $0.48 $0.41 $0.31 $0.46 $0.50 <-12 mths -9.53% <-IRR #YR-> 5 CF less WC 5 Yr Run #DIV/0! US$
Increase 145.70% -31.62% -16.91% -33.22% 8.05% -17.62% -12.97% -25.52% 50.18% 7.12% <-12 mths -9.53% <-IRR #YR-> 5 CF less WC 5 Yr Run -39.40% US$
5 year Running Average $0.86 $0.86 $0.67 $0.56 $0.46 $0.45 $0.43 <-12 mths -2.34% <-IRR #YR-> 9 CFPS - Less WC #DIV/0! US$
P/CF on Med Price 15.37 6.26 9.63 19.14 27.36 23.71 19.16 12.40 10.08 7.15 6.49 <-12 mths -2.82% <-IRR #YR-> 5 CFPS - Less WC -13.34% US$
P/CF on Closing Price 13.30 5.41 12.07 23.71 25.89 19.98 15.24 7.70 8.72 7.41 6.57 <-12 mths -12.15% <-IRR #YR-> 5 CFPS 5 yr Running #DIV/0! US$
CF/-WC P/CF Med 10 yr 11.38 5 yr  12.35 P/CF Med 10 yr 13.89 5 yr  12.40 -52.68% Diff M/C -12.15% <-IRR #YR-> 5 CFPS 5 yr Running -47.69% US$
$0.000 <-12 mths -100.00%
CF fr Op $M CDN$ $29.214 $34.080 $44.673 $34.299 $11.897 $20.829 $22.946 $20.883 $11.516 $23.478 $27.554 <-12 mths -19.63% <-Total Growth 9 Cash Flow CDN$
Increase 16.65% 31.09% -23.22% -65.31% 75.08% 10.17% -8.99% -44.86% 103.88% 17.36% <-12 mths SO Buy Back, DRIP S Iss
5 year Running Average $31 $29 $27 $22 $18 $20 $21 <-12 mths -31.64% <-Total Growth 5 CF 5 Yr Running CDN$
CFPS CDN$ $1.16 $1.35 $1.64 $1.10 $0.37 $0.64 $0.71 $0.65 $0.36 $0.75 $0.88 <-12 mths -35.04% <-Total Growth 9 Cash Flow per Share CDN$
Increase 16.65% 21.40% -32.53% -66.15% 71.69% 10.49% -7.92% -44.53% 107.27% 17.36% <-12 mths -2.40% <-IRR #YR-> 9 Cash Flow #DIV/0! CDN$
5 year Running Average $1.12 $1.02 $0.89 $0.70 $0.55 $0.62 $0.67 <-12 mths 14.56% <-IRR #YR-> 5 Cash Flow 97.35% CDN$
P/CF on Med Price 10.24 8.20 7.44 17.44 49.57 27.44 17.10 10.57 11.29 6.32 5.21 <-12 mths -4.68% <-IRR #YR-> 9 Cash Flow per Share #DIV/0! CDN$
P/CF on Closing Price 8.86 7.10 8.95 23.09 48.15 23.37 13.86 6.05 10.85 6.42 5.08 <-12 mths 14.96% <-IRR #YR-> 5 Cash Flow per Share 100.81% CDN$
-53.48% Diff M/C -11.12% <-IRR #YR-> 5 CFPS 5 yr Running #DIV/0! CDN$
$21.43 <-12 mths 7.92%
Excl.Working Capital CF -$9.755 $10.592 -$8.806 -$2.012 $9.759 $2.932 -$2.095 -$3.369 $2.593 -$3.625 $21.426 <-12 mths -11.12% <-IRR #YR-> 5 CFPS 5 yr Running -44.53% CDN$
CF fr Op $M WC CDN$ $19.460 $44.671 $35.868 $32.287 $21.656 $23.761 $20.851 $17.514 $14.108 $19.853 $21.426 <-12 mths 2.02% <-Total Growth 9 Cash Flow less WC CDN$
Increase 129.56% -19.71% -9.98% -32.93% 9.72% -12.25% -16.00% -19.44% 40.72% 7.92% <-12 mths 0.22% <-IRR #YR-> 9 Cash Flow less WC #DIV/0! CDN$
5 year Running Average $31 $32 $27 $23 $20 $19 $19 <-12 mths -1.72% <-IRR #YR-> 5 Cash Flow less WC -8.32% CDN$
CFPS Excl. WC CDN$ $0.77 $1.77 $1.31 $1.04 $0.68 $0.73 $0.64 $0.55 $0.44 $0.63 $0.69 <-12 mths -9.00% <-IRR #YR-> 5 CF less WC 5 Yr Run #DIV/0! CDN$
Increase 129.56% -25.64% -20.89% -34.54% 7.60% -11.99% -15.02% -18.97% 43.06% 7.92% <-12 mths -9.00% <-IRR #YR-> 5 CF less WC 5 Yr Run -37.58% CDN$
5 year Running Average $1.11 $1.11 $0.88 $0.73 $0.61 $0.60 $0.59 <-12 mths -2.12% <-IRR #YR-> 9 CFPS - Less WC #DIV/0! CDN$
P/CF on Med Price 15.37 6.26 9.27 18.52 27.23 24.06 18.82 12.60 9.22 7.47 6.70 <-12 mths -1.38% <-IRR #YR-> 5 CFPS - Less WC -6.72% CDN$
P/CF on Closing Price 13.30 5.41 11.15 24.53 26.45 20.49 15.25 7.21 8.86 7.59 6.54 <-12 mths -11.63% <-IRR #YR-> 5 5 yr Running #DIV/0! CDN$
*Operational Cash Flow per share  CF/-WC P/CF Med 10 yr 10.93 5 yr  11.29 P/CF Med 10 yr 13.98 5 yr  12.60 -53.24% Diff M/C -11.63% <-IRR #YR-> 5 5 yr Running -46.10% CDN$
G&M used Changed in WC and other items.
-$0.37 $0.00 $0.00 $0.00 $0.00 $0.75 Cash Flow per Share CDN$
-$1.12 $0.00 $0.00 $0.00 $0.00 $0.62 CFPS 5 yr Running CDN$
-$1.12 $0.00 $0.00 $0.00 $0.00 $0.62 CFPS 5 yr Running CDN$
-$19 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $20 Cash Flow less WC CDN$
-$22 $0.00 $0.00 $0.00 $0.00 $20 Cash Flow less WC CDN$
-$31 $0 $0 $0 $0 $19 CF less WC 5 Yr Run CDN$
-$31 $0 $0 $0 $0 $19 CF less WC 5 Yr Run CDN$
OPM 40.27% 36.18% 53.32% 48.76% 16.65% 27.38% 27.56% 25.03% 14.13% 30.86% 34.40% -23.35% <-Total Growth 9 OPM CDN$
Increase -10.15% 47.37% -8.56% -65.85% 64.40% 0.68% -9.18% -43.53% 118.36% 11.46% Should increase  or be stable. CDN$
Diff from Median 37.8% 23.9% 82.5% 66.9% -43.0% -6.3% -5.7% -14.3% -51.6% 5.7% 17.8% 0.00 <-Median-> 10 OPM CDN$
*Operational Profit Margin (CF/Revenue) Ratio OPM 10 Yrs 29.21% 5 Yrs 27.38% should be  zero, it is a   check on calculations CDN$
$19.263 <-12 mths -1.82%
Adjusted EBITDA $38.536 $55.881 $41.096 $31.643 $24.139 $26.334 $23.827 $21.052 $16.648 $19.620 $19.340 $23.450 $32.650 -49.09% <-Total Growth 9 Adjusted EBITDA US$
Change 45.01% -26.46% -23.00% -23.71% 9.09% -9.52% -11.65% -20.92% 17.85% -1.43% 21.25% 39.23% -11.65% <-Median-> 9 Change US$
Margin 71.32% 74.43% 66.92% 58.43% 43.02% 43.88% 38.76% 33.38% 29.40% 35.35% 33.34% 36.46% 42.29% 43.45% <-Median-> 10 Margin US$
-$4.130 <-12 mths -0.58%
EBIT -$6.28 -$13.50 -$10.35 -$7.69 -$4.11 -$4.20 $1.50 $7.00 <-Total Growth 4 EBIT
Change -114.83% 23.33% 25.74% 46.58% -2.29% 135.71% 366.67% 24.54% <-Median-> 4 Change
Margin -10.47% -21.96% -16.41% -13.57% -7.40% -7.24% 2.33% 9.07% -13.57% <-Median-> 5 Margin
Long Term Debt US$ $166.499 $173.265 $158.114 $104.459 $91.822 $99.015 $86.844 $84.578 $82.045 $60.740 $46.678 $40.837 -71.96% <-Total Growth 10 Debt US$
Change 4.06% -8.74% -33.93% -12.10% 7.83% -12.29% -2.61% -2.99% -25.97% -23.15% -12.51% -10.42% <-Median-> 10 Change US$
Debt/Market Cap Ratio 0.86 0.90 0.82 0.33 0.16 0.22 0.23 0.36 0.80 0.71 0.44 0.40 0.40 <-Median-> 10 Debt/Market Cap Ratio US$
Assets/Current Liabilities Ratio 17.40 14.48 11.12 8.01 6.78 8.53 9.97 7.75 7.83 7.09 5.27 4.55 7.92 <-Median-> 10 Assets/Current Liabilities Ratio US$
Debt to Cash Flow (Years) 7.96 5.82 3.19 3.48 10.60 5.29 4.99 5.20 7.59 2.72 2.05 5.24 <-Median-> 10 Debt to Cash Flow (Years) US$
Intangibles US$ $306.014 $327.983 $312.659 $271.153 $252.050 $253.404 $229.181 $195.018 $162.344 $122.122 $105.626 $99.633 -65.48% <-Total Growth 10 Intangibles US$
Goodwill $8.299 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 0.00% <-Total Growth 10 Goodwill US$
Total $314.313 $327.983 $312.659 $271.153 $252.050 $253.404 $229.181 $195.018 $162.344 $122.122 $105.626 $99.633 -66.39% <-Total Growth 10 Total US$
Change 4.35% -4.67% -13.28% -7.05% 0.54% -9.56% -14.91% -16.75% -24.78% -13.51% -5.67% -11.42% <-Median-> 10 Change US$
Intangible/Market Cap Ratio 1.63 1.70 1.62 0.85 0.43 0.58 0.61 0.83 1.59 1.43 0.98 0.98 0.92 <-Median-> 10 Intangible/Market Cap Ratio
Current Assets US$ $57.112 $54.072 $65.036 $31.618 $63.100 $45.911 $43.751 $44.374 $44.095 $35.400 $29.094 $28.948 -49.06% <-Total Growth 10 Current Assets US$
Current Liabilities $22.035 $26.568 $34.602 $38.268 $47.139 $35.642 $27.672 $31.190 $26.688 $22.545 $26.121 $28.822 18.54% <-Total Growth 10 Current Liabilities US$
Liquidity 2.59 2.04 1.88 0.83 1.34 1.29 1.58 1.42 1.65 1.57 1.11 1.00 1.50 <-Median-> 10 Ratio US$
Liq. with CF aft div 2.59 2.85 2.66 1.66 1.80 1.41 1.99 1.81 2.15 1.93 1.77 1.70 1.93 <-Median-> 5 Ratio US$
Liq. CF re  Inv+Div  2.59 1.64 2.04 1.30 1.36 0.63 1.71 1.37 2.14 1.93 1.66 1.70 1.71 <-Median-> 5 Ratio US$
Assets US$ $383.308 $384.628 $384.646 $306.425 $319.671 $303.906 $275.905 $241.652 $209.060 $159.904 $137.529 $131.087 -64.12% <-Total Growth 10 Assets US$
Liabilities $188.534 $209.064 $204.264 $147.936 $141.472 $134.657 $115.169 $116.334 $116.334 $88.563 $75.859 $72.517 -59.76% <-Total Growth 10 Liabilities US$
Debt Ratio 2.03 1.84 1.88 2.07 2.26 2.26 2.40 2.08 1.80 1.81 1.81 1.81 1.98 <-Median-> 10 Ratio Same in US$ US$
Check $194.774 $175.564 $180.382 $158.489 $178.199 $169.249 $160.736 $125.318 $92.726 $71.341 $61.670 $58.570 US$
Estimates BVPS $1.84 $1.90 Estimates Estimates BVPS
Estimate Book Value $57.5 $59.4 Estimates Estimate Book Value
P/B Ratio (Close) 1.77 1.72 Estimates P/B Ratio (Close)
Difference from 10 year median 2.72% Diff M/C Estimates Difference from 10 yr med.
Total Book Value US$ $194.774 $175.564 $180.382 $158.489 $178.199 $169.249 $160.736 $125.318 $92.726 $71.341 $61.670 $58.570 $58.570 $58.570 -68.34% <-Total Growth 10 Book Value US$
Preference Shares  US$ $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 0.00% <-Total Growth 10 Preference Shares US$
Net Book Value US$ $194.774 $175.564 $180.382 $158.489 $178.199 $169.249 $160.736 $125.318 $92.726 $71.341 $61.670 $58.570 $58.570 $58.570 -68.34% <-Total Growth 10 Book Value US$
Book Value per Share $8.37 $6.95 $7.14 $5.81 $5.74 $5.32 $4.95 $3.87 $2.90 $2.24 $1.97 $1.87 $1.87 $1.87 -76.43% <-Total Growth 10 Book Value per Share US$
Change -16.99% 2.74% -18.63% -1.19% -7.30% -6.87% -21.80% -25.14% -22.61% -12.12% -5.03% 0.00% 0.00% 3.70% P/B Ratio Current/Historical Median US$
P/B Ratio (Median) 1.09 1.27 1.23 1.60 2.67 2.75 2.76 2.35 1.77 1.39 1.68 1.72 1.68 P/B Ratio Historical Median US$
P/B Ratio (Close) 0.99 1.10 1.07 2.00 3.31 2.60 2.33 1.87 1.10 1.20 1.74 1.74 1.74 1.74 -13.46% <-IRR #YR-> 10 Book Value per Share -76.43% US$
Change 10.94% -2.67% 87.45% 65.16% -21.34% -10.47% -19.66% -41.22% 8.96% 45.10% 0.07% 0.00% 0.00% -18.00% <-IRR #YR-> 5 Book Value per Share -62.92% US$
Leverage (A/BK) 1.97 2.19 2.13 1.93 1.79 1.80 1.72 1.93 2.25 2.24 2.23 2.24 0.00 0.00 2.03 <-Median-> 10 A/BV US$
Debt/Equity Ratio 0.97 1.19 1.13 0.93 0.79 0.80 0.72 0.93 1.25 1.24 1.23 1.24 0.00 0.00 1.03 <-Median-> 10 Debt/Eq Ratio US$
Book Value is Asset less Liabilities P/BV 10 yr Med 1.72 5 yr Med 1.77 0.92% Diff M/C 1.97 Historical 11 A/BV US$
OPM Ratio CDN$ 40.27% 36.18% 53.32% 48.76% 16.65% 27.38% 27.56% 25.03% 14.13% 30.86% 34.40% -23.35% <-Total Growth 9 OPM
Increase -10.15% 47.37% -8.56% -65.85% 64.40% 0.68% -9.18% -43.53% 118.36% 11.46% Should increase  or be stable.
Diff from Median 37.8% 23.9% 82.5% 66.9% -43.0% -6.3% -5.7% -14.3% -51.6% 5.7% 17.8% 0.00 <-Median-> 10 OPM
*Operational Profit Margin (CF/Revenue) Ratio OPM 10 Yrs 29.21% 5 Yrs 27.38% should be  zero, it is a   check on calculations
Long Term Debt CDN$ $230.558 $232.643 $198.354 $142.503 $119.258 $126.066 $110.101 $114.552 $108.513 $87.399 $63.977 $56.392 -72.25% <-Total Growth 10 Debt CDN$
Change 0.90% -14.74% -28.16% -16.31% 5.71% -12.66% 4.04% -5.27% -19.46% -26.80% -11.86% -13.70% <-Median-> 10 Change CDN$
Debt/Market Cap Ratio 0.86 0.90 0.82 0.36 0.15 0.22 0.23 0.36 0.86 0.70 0.42 0.40 0.39 <-Median-> 10 Debt/Market Cap Ratio CDN$
Assets/Current Liabilities Ratio 17.40 14.48 11.12 8.01 6.78 8.53 9.97 7.75 7.83 7.09 5.27 4.55 7.92 <-Median-> 10 Assets/Current Liabilities Ratio
Debt to Cash Flow (Years) 7.96 5.82 3.19 3.48 10.60 5.29 4.99 5.20 7.59 2.72 2.05 5.24 <-Median-> 10 Debt to Cash Flow (Years)
Intangibles CDN$ $423.751 $440.383 $392.231 $369.907 $327.363 $322.634 $290.556 $264.132 $214.716 $175.721 $144.771 $144.771 -65.84% <-Total Growth 10 Intangibles CDN$
Goodwill $11.492 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 0.00% <-Total Growth 10 Goodwill CDN$
Total $435.243 $440.383 $392.231 $369.907 $327.363 $322.634 $290.556 $264.132 $214.716 $175.721 $144.771 $137.583 -66.74% <-Total Growth 10 Total CDN$
Change 1.18% -10.93% -5.69% -11.50% -1.44% -9.94% -9.09% -18.71% -18.16% -17.61% -4.96% -10.44% <-Median-> 10 Change CDN$
Intangible/Market Cap Ratio 1.63 1.70 1.62 0.93 0.41 0.56 0.60 0.83 1.70 1.41 0.96 0.98 0.94 <-Median-> 10 Intangible/Market Cap Ratio CDN$
Current Assets CDN$ $79.085 $72.602 $81.588 $43.133 $81.954 $58.454 $55.468 $60.100 $58.320 $50.937 $39.876 $39.974 -49.58% <-Total Growth 10 Assets CDN$
Current Liabilities $30.513 $35.673 $43.408 $52.205 $61.224 $45.379 $35.083 $42.244 $35.298 $32.440 $35.801 $39.800 17.33% <-Total Growth 10 Liabilities CDN$
Liquidity 2.59 2.04 1.88 0.83 1.34 1.29 1.58 1.42 1.65 1.57 1.11 1.00 1.50 <-Median-> 10 Ratio Same in US$ CDN$
Liq. with CF aft div 2.59 2.85 2.66 1.66 1.80 1.41 1.99 1.81 2.15 1.93 1.77 1.70 Uses actual CDN dividends received Same in US$ CDN$
Liq. CF re  Inv+Div  2.59 1.64 2.04 1.30 1.36 0.63 1.71 1.37 2.14 1.93 1.66 1.70 US$ one above more accurate Same in US$ CDN$
Curr Long Term Debt $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $13.740 Same in US$ CDN$
Assets CDN$ $530.783 $516.440 $482.538 $418.025 $415.189 $386.933 $349.792 $327.293 $276.503 $230.086 $188.497 $181.018 -64.49% <-Total Growth 10 Assets CDN$
Liabilities $261.071 $280.710 $256.249 $201.814 $183.744 $171.445 $146.011 $157.563 $153.863 $127.433 $103.972 $100.139 -60.17% <-Total Growth 10 Liabilities CDN$
Debt Ratio 2.03 1.84 1.88 2.07 2.26 2.26 2.40 2.08 1.80 1.81 1.81 1.81 1.98 <-Median-> 10 Ratio CDN$
Check  $270 $236 $226 $216 $231 $215 $204 $170 $123 $103 $85 $81
Estimates BVPS $2.54 $2.62 Estimates Estimates BVPS
Estimate Book Value $79.5 $82.1 Estimates Estimate Book Value
P/B Ratio (Close) 1.76 1.71 Estimates P/B Ratio (Close)
Difference from 10 year median -0.80% Diff M/C Estimates Difference from 10 yr med.
Book Value Check $269.712 $235.730 $226.289 $216.211 $231.445 $215.488 $203.781 $169.731 $122.639 $102.653 $84.525 $80.879
Total Book Value CDN$ $269.712 $235.730 $226.289 $216.211 $231.445 $215.488 $203.781 $169.731 $122.639 $102.653 $84.525 $80.879 $80.879 $80.879 -68.66% <-Total Growth 10 Book Value CDN$
Preference Shares  CDN$ $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 0.00% <-Total Growth 10
Net Book Value CDN$ $269.712 $235.730 $226.289 $216.211 $231.445 $215.488 $203.781 $169.731 $122.639 $102.653 $84.525 $80.879 $80.879 $80.879 -68.66% <-Total Growth 10 Book Value CDN$
Book Value per Share $11.59 $9.33 $8.95 $7.92 $7.45 $6.77 $6.28 $5.25 $3.83 $3.23 $2.70 $2.59 $2.59 $2.59 -76.67% <-Total Growth 10 Book Value per Share CDN$
Change -19.51% -4.00% -11.52% -5.93% -9.13% -7.27% -16.46% -26.90% -15.81% -16.29% -4.31% 0.00% 0.00% -1.33% P/B Ratio Current/Historical Median CDN$
P/B Ratio (Median) 1.09 1.27 1.23 1.54 2.58 2.74 2.81 2.31 1.80 1.27 1.76 1.77 1.76 P/B Ratio Historical Median CDN$
P/B Ratio (Close) 0.99 1.10 1.07 1.85 3.42 2.66 2.39 1.87 1.03 1.22 1.78 1.73 1.73 2.77 -13.55% <-IRR #YR-> 10 Book Value per Share -76.67% CDN$
Change 10.94% -2.67% 73.09% 85.03% -22.32% -10.14% -21.55% -45.03% 18.17% 46.52% -2.86% 0.00% 59.67% -16.78% <-IRR #YR-> 5 Book Value per Share -60.09% CDN$
Leverage (A/BK) 1.97 2.19 2.13 1.93 1.79 1.80 1.72 1.93 2.25 2.24 2.23 2.24 2.03 <-Median-> 10 A/BV CDN$
Debt/Equity Ratio 0.97 1.19 1.13 0.93 0.79 0.80 0.72 0.93 1.25 1.24 1.23 1.24 1.03 <-Median-> 10 Debt/Eq Ratio CDN$
Median Values P/BV 10 yr Med 1.78 5 yr Med 1.80 -2.54% Diff M/C 1.97 Historical 11 A/BV
-$8.104 <-12 mths -8.94%
Comprehensive Income  US$ -$19.504 $4.455 -$38.202 -$12.634 -$12.774 -$12.178 -$31.817 -$25.109 -$27.027 -$8.900 54.37% <-Total Growth 9 Comprehensive Income US$
Increase 122.84% -957.51% 66.93% -1.11% 4.67% -161.27% 21.08% -7.64% 67.07% 4.7% <-Median-> 5 Comprehensive Income US$
5 Yr Running Average -$4 -$3 -$11 -$13 -$16 -$14 -$22 -$19 -$22 -$21 -8.35% <-IRR #YR-> 9 Comprehensive Income #DIV/0! US$
ROE US$ -11.1% 2.5% -24.1% -7.1% -7.5% -7.6% -25.4% -27.1% -37.9% -14.4% -6.97% <-IRR #YR-> 5 Comprehensive Income 72.03% US$
5Yr Median -7.5% -7.5% -7.6% -7.6% -25.4% -25.4% 208.25% <-IRR #YR-> 5 5 Yr Running Average #DIV/0! US$
% Difference from NI 31.0% -173.1% 54.0% -35.4% -16.7% -7.2% 34.8% -8.8% 37.5% -28.4% 208.25% <-IRR #YR-> 5 5 Yr Running Average -33.53% US$
Median Values Diff 5, 10 yr -8.0% -7.2% -25.4% <-Median-> 5 Return on Equity US$
Current Liability Coverage Ratio US$ 0.55 1.03 0.69 0.53 0.48 0.68 0.49 0.50 0.43 0.55 0.54   CFO / Current Liabilities US$
5 year Median 0.55 0.68 0.53 0.50 0.49 0.50 0.50 0.50 <-Median-> 5 Current Liability Cov Ratio US$
Asset Efficiency Ratio US$ 3.77% 9.26% 8.58% 7.78% 5.60% 6.79% 6.37% 6.33% 6.13% 10.53% 11.84% CFO / Total Assets US$
5 year Median 7.78% 7.78% 6.79% 6.37% 6.33% 6.37% 6.37% 6.4% <-Median-> 5 Return on Assets  US$
Return on Assets ROA US$ -2.51% -3.87% -1.59% -8.10% -6.12% -5.04% -4.75% -9.77% -13.17% -12.29% -9.04% -4.78% Net  Income/Assets Return on Assets US$
5Yr Median -3.87% -5.04% -5.04% -6.12% -6.12% -9.77% -9.77% -9.77% -9.8% <-Median-> 5 Asset Efficiency Ratio US$
Return on Equity ROE US$ -4.95% -8.48% -3.38% -15.65% -10.97% -9.06% -8.16% -18.83% -29.69% -27.55% -20.16% -10.69% Net Inc/ Shareholders' equity Return on Equity US$
5Yr Median -8.48% -9.06% -9.06% -10.97% -10.97% -18.83% -20.16% -20.16% -20.2% <-Median-> 5 Return on Equity US$
-$10.291 <-12 mths -17.21%
Net Income US$ -$9.638 -$14.893 -$6.097 -$24.806 -$19.552 -$15.331 -$13.117 -$23.598 -$27.531 -$19.655 -$12.430 -$6.26 -$1.05 $2.60 -28.97% <-Total Growth 10 Net Income US$
Increase -54.52% 59.06% -306.86% 21.18% 21.59% 14.44% -79.90% -16.67% 28.61% 36.76% 49.61% 83.24% 347.62% EPS/CF Ratio should not be higher than 1.00 US$
5 Yr Running Average -$14.997 -$16.136 -$15.781 -$19.281 -$19.826 -$19.846 -$19.266 -$17.896 -$13.386 -$7.360 2.58% <-IRR #YR-> 10 Net Income -28.97% US$
Operating Cash Flow $21.758 $27.166 $32.747 $26.408 $9.344 $16.429 $16.942 $15.789 $8.003 $17.130 -4.11% <-IRR #YR-> 5 Net Income 18.92% US$
Investment Cash Flow -$19.693 -$10.533 -$10.533 -$15.359 -$44.677 -$4.510 -$10.148 -$0.189 $11.735 -$1.703 4.26% <-IRR #YR-> 6 5 Yr Running Ave. #DIV/0! US$
Total Accrual -$16.958 -$22.730 -$47.020 -$30.601 $20.002 -$25.036 -$30.392 -$43.131 -$39.393 -$27.857 3.61% <-IRR #YR-> 5 5 Yr Running Ave. -19.40% US$
Total Assets $384.628 $384.646 $306.425 $319.671 $303.906 $275.905 $241.652 $209.060 $159.904 $137.529 Balance Sheet Assets US$
Accruals Ratio -4.41% -5.91% -15.34% -9.57% 6.58% -9.07% -12.58% -20.63% -24.64% -20.26% -20.26% <-Median-> 5 Ratio US$
EPS/CF Ratio -1.05 -0.17 -0.96 -0.84 -0.90 -0.71 -1.53 -2.05 -2.01 -0.84 -0.93 <-Median-> 10 EPS/CF Ratio US$
Chge in Close US$ -7.91% 0.00% 52.53% 63.20% -27.08% -16.62% -37.18% -56.00% -15.67% 27.51% -4.96% 0.00% 0.00% Count 11 Years of data US$
up/down up up up down up up up Count 7 63.64% US$
Meet Prediction? Yes Yes Yes % right Count 3 42.86% US$
Financial Cash Flow US$ -$21.738 -$18.210 -$42.856 $23.947 $9.564 -$11.398 -$6.856 -$14.639 -$23.364 -$21.556 C F Statement  Financial Cash Flow US$
Total Accruals $4.780 -$4.520 -$4.164 -$54.548 $10.438 -$13.638 -$23.536 -$28.492 -$16.029 -$6.301 Accruals US$
Accruals Ratio 1.24% -1.18% -1.36% -17.06% 3.43% -4.94% -9.74% -13.63% -10.02% -4.58% -9.74% <-Median-> 5 Ratio US$
Cash US$ $57.112 $37.763 $36.219 $10.930 $47.078 $20.612 $21.179 $20.723 $21.995 $17.456 $11.723 $17.734 Cash US$
Cash per Share $2.45 $1.49 $1.43 $0.40 $1.52 $0.65 $0.65 $0.64 $0.69 $0.55 $0.37 $0.57 $0.64 <-Median-> 5 Cash per Share US$
Percentage of Stock Price 29.63% 19.59% 18.79% 3.44% 7.99% 4.68% 5.66% 8.83% 21.56% 20.41% 10.93% 17.39% 10.93% <-Median-> 5 % of Stock Price
-$11.11 <-12 mths -13.27%
Comprehensive Income CDN$ -$27.008 $5.982 -$47.924 -$17.235 -$16.591 -$15.505 -$40.338 -$34.008 -$35.746 -$12.806 52.58% <-Total Growth 9 Comprehensive Income CDN$
Increase 122.15% -901.18% 64.04% 3.74% 6.54% -160.16% 15.69% -5.11% 64.17% 6.5% <-Median-> 5 Comprehensive Income CDN$
5 Yr Running Average -$21 -$18 -$28 -$25 -$28 -$28 -7.96% <-IRR #YR-> 9 Comprehensive Income #DIV/0! CDN$
ROE CDN$ -11.5% 2.6% -22.2% -7.4% -7.7% -7.6% -23.8% -27.7% -34.8% -15.2% -5.05% <-IRR #YR-> 5 Comprehensive Income 22.81% CDN$
5Yr Median -11.5% -9.5% -7.7% -7.6% -7.7% -7.7% -23.8% -23.8% 6.13% <-IRR #YR-> 5 5 Yr Running Average #DIV/0! CDN$
% Difference from NI 35.1% -178.2% 41.6% -32.1% -15.0% -6.8% 26.2% -6.6% 26.4% -24.8% 6.13% <-IRR #YR-> 5 5 Yr Running Average -34.66% CDN$
Median Values Diff 5, 10 yr -6.7% -6.6% -23.8% <-Median-> 5 Return on Equity CDN$
Current Liability Coverage Ratio CDN$ 0.55 1.03 0.69 0.53 0.48 0.68 0.49 0.50 0.43 0.55 0.54   CFO / Current Liabilities CDN$
5 year Median 0.55 0.79 0.69 0.62 0.55 0.68 0.53 0.50 0.49 0.50 0.50 0.50 <-Median-> 5 Current Liability Cov Ratio CDN$
Asset Efficiency Ratio CDN$ 3.77% 9.26% 8.58% 7.78% 5.60% 6.79% 6.37% 6.33% 6.13% 10.53% 11.84% CFO / Total Assets CDN$
5 year Median 3.77% 6.51% 8.58% 8.18% 7.78% 7.78% 6.79% 6.37% 6.33% 6.37% 6.37% 6.4% <-Median-> 5 Return on Assets  CDN$
Return on Assets ROA CDN$ -2.51% -3.87% -1.59% -8.10% -6.12% -5.04% -4.75% -9.77% -13.17% -12.29% -9.04% -4.78% Net  Income/Assets Return on Assets CDN$
5Yr Median -2.51% -3.19% -2.51% -3.19% -3.87% -5.04% -5.04% -6.12% -6.12% -9.77% -9.77% -9.77% -9.8% <-Median-> 5 Asset Efficiency Ratio CDN$
Return on Equity ROE CDN$ -4.95% -8.48% -3.38% -15.65% -10.97% -9.06% -8.16% -18.83% -29.69% -27.55% -20.16% -10.69% Net Inc/ Shareholders' equity Return on Equity CDN$
5Yr Median -4.95% -6.72% -4.95% -6.72% -8.48% -9.06% -9.06% -10.97% -10.97% -18.83% -20.16% -20.16% -20.2% <-Median-> 5 Return on Equity CDN$
-$14.10 <-12 mths -17.21%
Net Income CDN$ -$13.346 -$19.997 -$7.649 -$33.840 -$25.394 -$19.519 -$16.630 -$31.961 -$36.413 -$28.282 -$17.037 -$8.650 -$1.450 $3.590 -27.65% <-Total Growth 10 Net Income CDN$
Increase -49.83% 61.75% -342.43% 24.96% 23.13% 14.80% -92.19% -13.93% 22.33% 39.76% 49.23% 83.24% 347.62% EPS/CF Ratio should not be higher than 1.00 CDN$
5 Yr Running Average -$20.045 -$21.280 -$20.606 -$25.469 -$25.983 -$26.561 -$26.064 -$24.468 -$18.366 -$10.366 2.47% <-IRR #YR-> 10 Net Income -27.65% CDN$
Operating Cash Flow $29.214 $36.476 $41.081 $36.026 $12.136 $20.917 $21.479 $21.385 $10.585 $24.648 -2.68% <-IRR #YR-> 5 Net Income 12.72% CDN$
Investment Cash Flow -$26.442 -$13.214 -$14.369 -$19.948 -$56.883 -$5.718 -$13.744 -$0.250 $16.885 -$2.334 4.47% <-IRR #YR-> 6 5 Yr Running Ave. #DIV/0! CDN$
Total Accrual -$22.770 -$30.911 -$60.552 -$41.472 $25.227 -$31.829 -$39.696 -$57.547 -$55.752 -$39.351 4.14% <-IRR #YR-> 5 5 Yr Running Ave. -22.48% CDN$
Total Assets $516.440 $482.538 $418.025 $415.189 $386.933 $349.792 $327.293 $276.503 $230.086 $188.497 Balance Sheet Assets CDN$
Accruals Ratio -4.41% -6.41% -14.49% -9.99% 6.52% -9.10% -12.13% -20.81% -24.23% -20.88% -20.81% <-Median-> 5 Ratio CDN$
EPS/CF Ratio -1.05 -0.17 -0.96 -0.84 -0.90 -0.71 -1.53 -2.05 -2.01 -0.84 -0.93 <-Median-> 10 EPS/CF Ratio CDN$
Change in Close 0.00% -10.71% -6.57% 53.15% 74.06% -29.41% -16.67% -34.47% -59.82% -0.51% 22.65% -7.05% 0.00% 59.67% Count 12 Years of data CDN$
up/down up up up down up up up up up Count 9 75.00% CDN$
Meet Prediction? Yes Yes Yes Yes % right Count 4 44.44% CDN$
Financial Cash Flow CDN$ -$29.188 -$22.844 -$58.464 $31.102 $12.177 -$14.450 -$9.286 -$19.362 -$33.618 -$29.545 C F Statement  Financial Cash Flow CDN$
Total Accruals $6.418 -$8.066 -$2.088 -$72.574 $13.050 -$17.379 -$30.410 -$38.186 -$22.133 -$9.806 Accruals CDN$
Accruals Ratio 1.24% -1.67% -0.50% -17.48% 3.37% -4.97% -9.29% -13.81% -9.62% -5.20% -9.29% <-Median-> 5 Ratio CDN$
Cash CDN$ $79.085 $50.704 $45.437 $14.911 $61.145 $26.243 $26.851 $28.067 $29.091 $25.117 $16.068 $12.326 Cash CDN$
Cash per Share $3.40 $2.01 $1.80 $0.55 $1.97 $0.82 $0.83 $0.87 $0.91 $0.79 $0.51 $0.39 $0.83 <-Median-> 5 Cash per Share CDN$
Percentage of Stock Price 29.63% 19.59% 18.79% 3.73% 7.72% 4.58% 5.52% 8.82% 23.03% 20.10% 10.66% 8.80% 10.66% <-Median-> 5 % of Stock Price CDN$
Notes:
May 29, 2029.  Last estimates were for 2025, 2026 and 2027 in US$ of $57.33M, $63.08M, $63.7M Revenue, -$0.32, -$0.18 2025/6, 
$12M 2025 FCF, $19.030M, $22.260M, $23750M EBITDA, $2.00, $1.96 2025/6 BVPS, -$10.02M, -$4.85M, -$3.7M Net Income,
May 20, 2025.  Last estimates were for 2024, 2025, 2026 of $58M, $65M, $69M US$ Revenue, -$0.60, -$0.40, -$0.58 US$ EPS, 
$9.6M, $9.6M 2024/5 US$ FCF, $2.54, $2.40 2014/5 US$ BVPS, -$18.3M, -$13.47M, -$18.62M US$ Net Income
May 19, 2024.  Last estimates were for 2023, 2024 and 2025 of $87M, $113M, $185M CDN$ Revenue, -$0.63, -$0.14, $0.05 CDN$ EPS, 
$23.8, $47.7M, $66M CDN$ FCF, $4.39, $4.36 CDN$ 2023/4 BVPS, -$20.3M, -$12M, $1.3M CDN$ Net Income.
May 21, 2023.  Last estimates were in CDN$ for 2022, 2023 and 2024 of $99M, $182M and $275M, -$0.18, $0.80 and $0.92 for EPS, 
$52.4M, $92.9M and $92.9M for FCF, $6.03 and $6.43 for BVPS, and -$9M, $14.4M and $37.3M for Net Income.
May 21, 2022.  Last estimates were for 2021, 2022 and 2023 of $69M, $150M and $242M US$ for Revenue, $0.50, $0.47 and $2.23 for EPS, 
$24.5M, $52.4M and $92.9M US$ for FCF and $-12.5M, $17.7M and 74.7M US$ for Net Income.
May 22, 2021.  Last estimates were for 2020 and 2021 of $59.5M and $76.5M US$ for Revenue, $0.36, $0.29 and 0.29 US$ for EPS for 2020 to 2022 and $9.425M US$ for Net Income
May 16, 2020.  Last estimates were for 2019 and 2020 of $81.3M, $72.1 for Revenue CDN$, $0.05 and $0.34 for EPS CDN$ and $2.09M and $12M for Net Income CDN$.
May 19, 2019.  Last estimates were for 2018, 2019 and 2020 of $82.4M, $81.5M and $56M for Revenue CDN$, -$0.49, -$0.29 and $0.10  for EPS CDN$ and -$10.4M, $-3.96M and $2.86M for Net Income CDN$.
Automular Corp bought into this stock.  Stock values bfore 2015 are for automodular Corp.
August 10, 2018 started to trade on US exchange.
March 23, 2018.  I paid $10.20 for shares in HLS with Automodular Corp shares.
In March 2018 HLS Therapeutics Inc. was listed publicly on the TSXV by way of a Reverse Take-Over of Automodular Corporation.
August 11. 2015.  Privated plancement of 20,000,000 shares for $200,000,000 or $10 a share US$ Exchge 1.3148
Sector:
Health Care, Consumer
What should this stock accomplish?
Would I buy this company and Why.
Why am I following this stock. 
I got this stock because it did a reverse takeover of Automodular Corp (TSX-AM, OTC-AMZKF) on March 12, 2018.  
There was a plan of arrangement whereby Automodular shareholders got 0.165834 HLS common shares and one HLS preferred share.  
The HLS preferred shares were a form of contingent value right allowing AMD shareholders to have an equity stake linked to the 
outcome of litigation that had been ongoing for several years between AMD and General Motors.
I bought some stock in 2018, 2020 and 2023 because this is a Health Care sector stock and there are few of them in the Canadian market.
Dividends
Dividends are paid quarterly in Cycle 1 of January,m April, July and October.  Dividends are declared in one month for shareholders of record of the that month and paid in the next month.
For example, the dividends declared on December 15, 2015 are for shareholders of Record of December 31, 2015 and was paid on January 15, 2016.
This company changed dividends from monthly to quarterly in 2016.
Misson Statement or closes thing I can find.
What I am looking for is a statement that the company wants to do well by their customers, employees, and community and and thereby earn shareholders a reasonable return.
For customers 
For employees 
For community 
For investors 
Why I bought this stock.
How they make their money.
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical 
products in the North American markets.  The company operates in Canada, the United States, and the Rest of world, with the majority of its 
revenue generated from Canada.
Shares; '%, Value $M %, Val $M Shares %, Val $M Shares %, Val $M Shares %, Val $M Shares %, Val $M Shares %, Val $M Shares %, Val $M Shares %, Val $M Shares %, Val $M Change
Date 2018 May 2019 May 16 2020 May 22 2021 May 21 2022 May 21 2023 May 19 2024 May 20 2025 May 29 2026
Millian, Graig 0.005 0.02% 0.013 0.04% 0.013 0.04% 0.013 0.04% 0.00%
CEO - Shares - Amount $0.020 $0.049 $0.060 $0.056
Options - percentage 0.600 1.88% 0.900 2.83% 1.185 3.79% 1.185 3.79% 0.00%
Options - amount $2.370 $3.537 $5.712 $5.309
Godin, Bilbert 0.912 2.87% 0.920 2.84% 0.927 2.87% Ceased insider May 2023
CEO - Shares - Amount $16.416 $13.800 $9.112
Options - percentage 0.714 2.24% 0.839 2.59% 1.180 3.65%
Options - amount $12.856 $12.589 $11.596
Hanna, John Gordon 0.004 0.01% 0.008 0.03% 0.008 0.03% Interium CFO 0.00%
CFO - Shares - Amount $0.016 $0.039 $0.036
Options - percentage 0.126 0.40% 0.226 0.72% 0.226 0.72% 0.00%
Options - amount $0.496 $1.090 $1.013
Hendrickson, Tim 0.08% 0.022 0.07% 0.022 0.07% 0.030 0.09% 0.048 0.15% 0.058 0.18% Among Other officers  #DIV/0!
CFO - Shares - Amount $0.322 $0.561 $0.396 $0.450 $0.467 $0.227 Ceased Insider Jan 2024
Options - percentage 0.15% 0.410 1.32% 0.083 0.26% 0.128 0.40% 0.194 0.60% 0.273 0.85% #DIV/0!
Options - amount $0.600 $10.444 $1.501 $1.926 $1.911 $1.079
Gross, Jason A 0.050 0.16% 0.050 0.16% 0.050 0.15% 0.050 0.15% 0.050 0.16% 0.050 0.16% 0.050 0.16% 0.050 0.16% 0.00%
Officer - Shares - Amount $1.262 $0.895 $0.746 $0.489 $0.196 $0.195 $0.240 $0.223
Options - percentage 0.093 0.30% 0.105 0.33% 0.133 0.41% 0.144 0.45% 0.159 0.50% 0.211 0.67% 0.236 0.76% 0.236 0.76% 0.00%
Options - amount $2.365 $1.886 $1.992 $1.419 $0.630 $0.831 $1.140 $1.059
Lennox, Ryan Christopher 0.001 0.00% 0.001 0.00% 0.001 0.00% 0.001 0.00% 0.00%
Officer - Shares - Amount $0.002 $0.002 $0.002 $0.002
Options - percentage 0.136 0.42% 0.268 0.84% 0.226 0.72% 0.343 1.10% 51.46%
Options - amount $0.536 $1.052 $1.090 $1.535
Bastien, Yvon 0.00% 0.000 0.00% 0.000 0.00% 0.000 0.00% 0.000 0.00% 0.000 0.00%
Director - Shares - Amount $0.000 $0.000 $0.000 $0.000 $0.000 $0.000
Options - percentage 0.24% 0.065 0.21% 0.079 0.25% 0.087 0.27% 0.100 0.31% 0.120 0.37%
Options - amount $0.952 $1.657 $1.416 $1.300 $0.979 $0.473
Beaucham, Norma 0.001 0.00% 0.001 0.00% 0.001 0.00% 0.001 0.00% 0.00%
Director - Shares - Amount $0.002 $0.002 $0.002 $0.002
Options - percentage 0.036 0.11% 0.095 0.30% 0.119 0.38% 0.138 0.44% 16.05%
Options - amount $0.142 $0.372 $0.572 $0.617
Hill, Rodney 0.000 0.00% 0.000 0.00% 0.000 0.00% 0.000 0.00% Chair 2024 #DIV/0!
Director - Shares - Amount $0.000 $0.000 $0.000 $0.000
Options - percentage 0.063 0.20% 0.118 0.37% 0.136 0.43% 0.150 0.48% 10.58%
Options - amount $0.250 $0.462 $0.655 $0.673
Welborn, John Lee 0.000 0.00% 0.097 0.31% 0.141 0.45% 0.141 0.45% Among Other officers  0.00%
Chairman - Shares - Amt $0.000 $0.381 $0.681 $0.633 Last filed Apr 2021
Options - percentage 0.046 0.14% 0.132 0.42% 0.195 0.62% 0.242 0.77% No longer CEO 2021 24.35%
Options - amount $0.180 $0.521 $0.939 $1.085 Dir in 2021, Chair 2023
Gubitz, Gregory David 2.44% 0.667 2.15% 0.912 2.87% 0.325 1.00% 0.225 0.70% 0.050 0.16%
Chairman - Shares - Amt $9.772 $17.009 $16.416 $4.875 $2.212 $0.198
Options - percentage 2.23% 0.607 1.96% 0.654 2.06% 0.808 2.49% 0.821 2.54% 0.843 2.64%
Options - amount $8.899 $15.489 $11.776 $12.120 $8.069 $3.329
Wells, William M. 4.59% 1.252 4.03% 0.962 3.02% 0.942 2.90% 0.839 2.59% reported Jan 2020
Chairman - Shares - Amt $18.345 $31.932 $17.321 $14.135 $8.243
Options - percentage 2.08% 0.569 1.83% 0.630 1.98% 0.710 2.19% 0.794 2.45%
Options - amount $8.336 $14.511 $11.341 $10.651 $7.802 Ceased inisder Aug 2020
Athyrium Opportunities II Co-Invest 1LP 15.11% 4.125 13.28% 4.352 13.68% 4.352 13.41% 4.352 13.45% 4.352 13.61%
10% Holder $60.431 $105.188 $78.332 $65.277 $42.778 $17.190 Zero in 2018; 2024
Polar Securities Inc 6.367 19.91% 6.367 20.36% 6.367 20.36% 0.00%
10% Holder $25.150 $30.689 $28.525
Increase in O/S Shares 1.82% 0.000 0.00% 0.002 0.01% 0.006 0.02% 0.418 1.29% 0.022 0.07% 0.022 0.07% 0.000 0.00% 0.000 0.00% Average 0.28%
Due to SO $4.391 $0.000 $0.054 $0.111 $6.272 $0.215 $0.085 $0.000 $0.000 Zero 2025
Book Value $4.446 $0.000 $0.014 $0.061 $5.332 $0.251 $0.178 $0.668 $0.918 Look for exercised options
Insider Buying -$0.143 -$0.143 -$0.560 -$0.267 -$0.237 -$0.067 -$0.522 -$0.022 -$0.003
Insider Selling $0.000 $0.000 $5.459 $6.238 $4.049 $2.100 $0.000 $0.002 $0.000
Net Insider Selling -$0.143 -$0.143 $4.898 $5.971 $3.812 $2.033 -$0.522 -$0.020 -$0.003
Net Selling % of Market Cap -0.04% -0.02% 0.86% 1.23% 1.20% 1.61% -0.42% -0.01% 0.00%
Directors 7 7 8 10 10 8 7 8
Women 0% 1 14% 1 14% 1 13% 2 20% 2 20% 2 25% 1 14% 1 13%
Minorities 0% 0 0% 0 0% 0 0% 0 0% 0 0% 0 0% 0 0% 0 0%
Institutions/Holdings 76.60% 9 87.61% 20 9.47% 20 24.08% 20 11.61% 20 0.42% 20 6.54%
Total Shares Held 76.65% 23.914 76.99% 2.912 9.15% 7.661 23.61% 3.771 11.65% 0.133 0.42% 0.000 0.00%
Increase/Decrease 3 Mths 0.00% 3.297 15.99% -0.074 -2.48% -0.059 -0.76% 0.000 0.01% -0.373 -73.78% -0.566 -100.00%
Starting No. of Shares 20.617 2.986 7.720 MS Major 20 3.770 MS Major 20 0.505 MS Major 20 0.566 MS Major 20
Copyright © 2008 Website of SPBrunner. All rights reserved.
My stock  Div